Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects

Status:
Completed

Trial end date:
2018-01-16

Target enrollment:

Participant gender:

The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of xisomab 3G3 in healthy adult subjects.

Phase 1

Aronora, Inc.